Glycocapture-based proteomics for secretome analysis

Proteomics

Volumn 13, Issue 3-4, 2013, Pages 512-525

  Lai, Zon W ^a   Nice, Edouard C ^b   Schilling, Oliver ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Biomarker; Degradomics; Glycoprotein; Glycoproteomics; PTM; Secretome

Indexed keywords

GLYCOPROTEIN; HYDRAZINE; LECTIN; PROTEOME; SECRETOME; SIALIC ACID; TITANIUM DIOXIDE; UNCLASSIFIED DRUG;

CELL SURFACE; CHEMICAL LABELING; GLYCOCAPTURE BASED PROTEOMIC; GLYCOSYLATION; HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PURIFICATION; PROTEOMICS; QUANTITATIVE ANALYSIS; REVIEW;

ANIMALS; CHROMATOGRAPHY, AFFINITY; CLICK CHEMISTRY; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; HYDRAZINES; LECTINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOME; PROTEOMICS; STAINING AND LABELING; TITANIUM;

EID: 84873990832     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201200414     Document Type: Review

References (142)

1. Makridakis, M., Vlahou, A., Secretome proteomics for discovery of cancer biomarkers. J. Proteomics 2010, 73, 2291-2305.
2. Ji, H., Goode, R. J., Vaillant, F., Mathivanan, S. et al., Proteomic profiling of secretome and adherent plasma membranes from distinct mammary epithelial cell subpopulations. Proteomics 2011, 11, 4029-4039.
3. Ranganath, S. H., Levy, O., Inamdar, M. S., Karp, J. M., Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 2012, 10, 244-258.
4. Pardo, M., Roca-Rivada, A., Seoane, L. M., Casanueva, F. F., Obesidomics: contribution of adipose tissue secretome analysis to obesity research. Endocrine 2012, 41, 374-383.
5. Carvalho, M. M., Teixeira, F. G., Reis, R. L., Sousa, N., Salgado, A. J., Mesenchymal stem cells in the umbilical cord: phenotypic characterization, secretome and applications in central nervous system regenerative medicine. Curr. Stem Cell Res. Ther. 2011, 6, 221-228.
6. Makawita, S., Smith, C., Batruch, I., Zheng, Y. et al., Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers. Mol. Cell Proteomics 2011, 10, M111 008599.
7. Planque, C., Kulasingam, V., Smith, C. R., Reckamp, K. et al., Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines. Mol. Cell Proteomics 2009, 8, 2746-2758.
8. Duffy, M. J., van Dalen, A., Haglund, C., Hansson, L. et al., Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur. J. Cancer 2007, 43, 1348-1360.
9. Bloom, G. C., Eschrich, S., Zhou, J. X., Coppola, D., Yeatman, T. J., Elucidation of a protein signature discriminating six common types of adenocarcinoma. Int. J. Cancer 2007, 120, 769-775.
10. Hakomori, S., Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv. Cancer Res. 1989, 52, 257-331.
11. Kim, Y. J., Varki, A., Perspectives on the significance of altered glycosylation of glycoproteins in cancer. Glycoconj. J. 1997, 14, 569-576.
12. Brooks, S. A., Carter, T. M., Royle, L., Harvey, D. J. et al., Altered glycosylation of proteins in cancer: what is the potential for new anti-tumour strategies. Anticancer Agents Med. Chem. 2008, 8, 2-21.
13. Weston, A. D., Hood, L., Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. J. Proteome Res. 2004, 3, 179-196.
14. Satake, K., Takeuchi, T., Homma, T., Ozaki, H., CA19-9 as a screening and diagnostic tool in symptomatic patients: the Japanese experience. Pancreas 1994, 9, 703-706.
15. Kim, J. E., Lee, K. T., Lee, J. K., Paik, S. W. et al., Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population. J. Gastroenterol. Hepatol. 2004, 19, 182-186.
16. Chang, C. Y., Huang, S. P., Chiu, H. M., Lee, Y. C. et al., Low efficacy of serum levels of CA 19-9 in prediction of malignant diseases in asymptomatic population in Taiwan. Hepatogastroenterology 2006, 53, 1-4.
17. Kannagi, R., Carbohydrate antigen sialyl Lewis a-its pathophysiological significance and induction mechanism in cancer progression. Chang Gung Med. J. 2007, 30, 189-209.
18. Ballehaninna, U. K., Chamberlain, R. S., The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: an evidence based appraisal. J. Gastrointest. Oncol. 2012, 3, 105-119.
19. Duffy, M. J., van Dalen, A., Haglund, C., Hansson, L. et al., Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. Eur. J. Cancer 2003, 39, 718-727.
20. Baker, F., Denniston, M., Smith, T., West, M. M., Adult cancer survivors: how are they faring? Cancer 2005, 104(11 Suppl), 2565-2576.
21. Leach, F. S., Koh, M. S., Chan, Y. W., Bark, S. et al., Prostate specific antigen as a clinical biomarker for prostate cancer: what's the take home message? Cancer Biol. Ther. 2005, 4, 371-375.
22. MacBeath, G., Protein microarrays and proteomics. Nat. Genet. 2002, 32(Suppl), 526-532.
23. Wulfkuhle, J. D., Liotta, L. A., Petricoin, E. F., Proteomic applications for the early detection of cancer. Nat. Rev. Cancer 2003, 3, 267-275.
24. Hawkridge, A. M., Muddiman, D. C., Mass spectrometry-based biomarker discovery: toward a global proteome index of individuality. Annu. Rev. Anal. Chem. (Palo Alto Calif) 2009, 2, 265-277.
25. Rajcevic, U., Niclou, S. P., Jimenez, C. R., Proteomics strategies for target identification and biomarker discovery in cancer. Front Biosci. 2009, 14, 3292-3303.
26. Michalski, A., Damoc, E., Hauschild, J. P., Lange, O. et al., Mass spectrometry-based proteomics using Q Exactive, a high-performance benchtop quadrupole Orbitrap mass spectrometer. Mol. Cell Proteomics 2011, 10, M111 011015.
27. Andrews, G. L., Simons, B. L., Young, J. B., Hawkridge, A. M., Muddiman, D. C., Performance characteristics of a new hybrid quadrupole time-of-flight tandem mass spectrometer (TripleTOF 5600). Anal. Chem. 2011, 83, 5442-5446.
28. May, C., Brosseron, F., Chartowski, P., Schumbrutzki, C. et al., Instruments and methods in proteomics. Methods Mol. Biol. 2011, 696, 3-26.
29. Kislinger, T., Cox, B., Kannan, A., Chung, C. et al., Global survey of organ and organelle protein expression in mouse: combined proteomic and transcriptomic profiling. Cell 2006, 125, 173-186.
30. Omenn, G. S., States, D. J., Adamski, M., Blackwell, T. W. et al., Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 2005, 5, 3226-3245.
31. Adachi, J., Kumar, C., Zhang, Y., Olsen, J. V., Mann, M., The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol. 2006, 7, R80.
32. Verberkmoes, N. C., Russell, A. L., Shah, M., Godzik, A. et al., Shotgun metaproteomics of the human distal gut microbiota. ISME J. 2009, 3, 179-189.
33. Jimenez, C. R., Knol, J. C., Meijer, G. A., Fijneman, R. J., Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers. J. Proteomics 2010, 73, 1873-1895.
34. Wu, S. L., Kim, J., Hancock, W. S., Karger, B., Extended Range Proteomic Analysis (ERPA): a new and sensitive LC-MS platform for high sequence coverage of complex proteins with extensive post-translational modifications-comprehensive analysis of beta-casein and epidermal growth factor receptor (EGFR). J. Proteome Res. 2005, 4, 1155-1170.
35. Nagae, M., Yamaguchi, Y., Function and 3D structure of the N-glycans on glycoproteins. Int. J. Mol. Sci. 2012, 13, 8398-8429.
36. Dallas, D. C., Martin, W. F., Hua, S., German, J. B., Automated glycopeptide analysis-review of current state and future directions. Brief Bioinform. 2012, doi: 10.1093/bib/bbs045.
37. Hua, S., An, H. J., Glycoscience aids in biomarker discovery. BMB Rep. 2012, 45, 323-330.
38. Wang, L. X., Lomino, J. V., Emerging technologies for making glycan-defined glycoproteins. ACS Chem. Biol. 2012, 7, 110-122.
39. Lowe, J. B., Marth, J. D., A genetic approach to Mammalian glycan function. Annu. Rev. Biochem. 2003, 72, 643-691.
40. Spiro, R. G., Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. Glycobiology 2002, 12, 43R-56R.
41. Zhang, H., Loriaux, P., Eng, J., Campbell, D. et al., UniPep-a database for human N-linked glycosites: a resource for biomarker discovery. Genome Biol. 2006, 7, R73.
42. Janecki, D. J., Pomerantz, S. C., Beil, E. J., Nemeth, J. F., A fully integrated multi-column system for abundant protein depletion from serum/plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2012, 902, 35-41.
43. Zhu, S., Zhang, X., Gao, M., Yan, G., Zhang, X., [Construction of a two-dimensional liquid chromatography separation system for high abundance proteins depletion in human plasma]. Se Pu 2011, 29, 837-842.
44. Nice, E. C., Rothacker, J., Weinstock, J., Lim, L., Catimel, B., Use of multidimensional separation protocols for the purification of trace components in complex biological samples for proteomics analysis. J. Chromatogr. A 2007, 1168, 190-210; discussion 189.
45. Tang, H. Y., Ali-Khan, N., Echan, L. A., Levenkova, N. et al., A novel four-dimensional strategy combining protein and peptide separation methods enables detection of low-abundance proteins in human plasma and serum proteomes. Proteomics 2005, 5, 3329-3342.
46. McDonald, C. A., Yang, J. Y., Marathe, V., Yen, T. Y., Macher, B. A., Combining results from lectin affinity chromatography and glycocapture approaches substantially improves the coverage of the glycoproteome. Mol. Cell Proteomics 2009, 8, 287-301.
47. O'Shannessy, D. J., Quarles, R. H., Labeling of the oligosaccharide moieties of immunoglobulins. J. Immunol. Methods 1987, 99, 153-161.
48. Zhang, H., Li, X. J., Martin, D. B., Aebersold, R., Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat. Biotechnol. 2003, 21, 660-666.
49. Alvarez-Manilla, G., Atwood, J., 3rd, Guo, Y., Warren, N. L. et al., Tools for glycoproteomic analysis: size exclusion chromatography facilitates identification of tryptic glycopeptides with N-linked glycosylation sites. J. Proteome Res. 2006, 5, 701-708.
50. Hung, C. W., Tholey, A., Tandem mass tag protein labeling for top-down identification and quantification. Anal. Chem. 2012, 84, 161-170.
51. Laughlin, S. T., Agard, N. J., Baskin, J. M., Carrico, I. S. et al., Metabolic labeling of glycans with azido sugars for visualization and glycoproteomics. Methods Enzymol. 2006, 415, 230-250.
52. Kawanishi, S., Inoue, S., Yamamoto, K., Hydroxyl radical and singlet oxygen production and DNA damage induced by carcinogenic metal compounds and hydrogen peroxide. Biol. Trace Elem. Res. 1989, 21, 367-372.
53. Baskin, J. M., Prescher, J. A., Laughlin, S. T., Agard, N. J. et al., Copper-free click chemistry for dynamic in vivo imaging. Proc. Natl. Acad. Sci. USA 2007, 104, 16793-16797.
54. Saxon, E., Bertozzi, C. R., Cell surface engineering by a modified Staudinger reaction. Science 2000, 287, 2007-2010.
55. Chang, P. V., Prescher, J. A., Hangauer, M. J., Bertozzi, C. R., Imaging cell surface glycans with bioorthogonal chemical reporters. J. Am. Chem. Soc. 2007, 129, 8400-8401.
56. Breinbauer, R., Kohn, M., Azide-alkyne coupling: a powerful reaction for bioconjugate chemistry. Chembiochem 2003, 4, 1147-1149.
57. Wang, Q., Chan, T. R., Hilgraf, R., Fokin, V. V. et al., Bioconjugation by copper(I)-catalyzed azide-alkyne [3 + 2] cycloaddition. J. Am. Chem. Soc. 2003, 125, 3192-3193.
58. Rostovtsev, V. V., Green, L. G., Fokin, V. V., Sharpless, K. B., A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes. Angew. Chem. Int. Ed. Engl. 2002, 41, 2596-2599.
59. Kolb, H. C., Finn, M. G., Sharpless, K. B., Chemistry: diverse chemical function from a few good reactions. Angew. Chem. Int. Ed. Engl. 2001, 40, 2004-2021.
60. Agard, N. J., Baskin, J. M., Prescher, J. A., Lo, A., Bertozzi, C. R., A comparative study of bioorthogonal reactions with azides. ACS Chem. Biol. 2006, 1, 644-648.
61. Kuhn, P. H., Koroniak, K., Hogl, S., Colombo, A. et al., Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons. EMBO J. 2012, 31, 3157-3168.
62. O'Shannessy, D. J., Dobersen, M. J., Quarles, R. H., A novel procedure for labeling immunoglobulins by conjugation to oligosaccharide moieties. Immunol. Lett. 1984, 8, 273-277.
63. Bobbitt, J. M., Periodate oxidation of carbohydrates. Adv. Carbohydr. Chem. 1956, 48, 1-41.
64. Abraham, R., Moller, D., Gabel, D., Senter, P. et al., The influence of periodate oxidation on monoclonal antibody avidity and immunoreactivity. J. Immunol. Methods 1991, 144, 77-86.
65. Dirksen, A., Dirksen, S., Hackeng, T. M., Dawson, P. E., Nucleophilic catalysis of hydrazone formation and transimination: implications for dynamic covalent chemistry. J. Am. Chem. Soc. 2006, 128, 15602-15603.
66. Zhang, H., Yi, E. C., Li, X. J., Mallick, P. et al., High throughput quantitative analysis of serum proteins using glycopeptide capture and liquid chromatography mass spectrometry. Mol. Cell Proteomics 2005, 4, 144-155.
67. Tian, Y., Kelly-Spratt, K. S., Kemp, C. J., Zhang, H., Mapping tissue-specific expression of extracellular proteins using systematic glycoproteomic analysis of different mouse tissues. J. Proteome Res. 2010, 9, 5837-5847.
68. Wollscheid, B., Bausch-Fluck, D., Henderson, C., O'Brien, R. et al., Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins. Nat. Biotechnol. 2009, 27, 378-386.
69. Boysen, G., Bausch-Fluck, D., Thoma, C. R., Nowicka, A. M. et al., Identification and functional characterization of pVHL-dependent cell surface proteins in renal cell carcinoma. Neoplasia 2012, 14, 535-546.
70. Bock, T., Moest, H., Omasits, U., Dolski, S. et al., Proteomic analysis reveals drug accessible cell surface N-glycoproteins of primary and established glioblastoma cell lines. J. Proteome Res. 2012, 11, 4885-4893.
71. Liu, T., Qian, W. J., Gritsenko, M. A., Camp, D. G., 2nd et al., Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. J. Proteome Res. 2005, 4, 2070-2080.
72. Kim, Y. J., Zaidi-Ainouch, Z., Gallien, S., Domon, B., Mass spectrometry-based detection and quantification of plasma glycoproteins using selective reaction monitoring. Nat. Protoc. 2012, 7, 859-871.
73. Fanayan, S., Hincapie, M., Hancock, W. S., Using lectins to harvest the plasma/serum glycoproteome. Electrophoresis 2012, 33, 1746-1754.
74. Goldstein, I. J., Poretz, R. D., The Lectins-Properties, Functions and Applications in Biology Medicine, Academic Press, Orlando 1986, pp. 33-243.
75. Debray, H., Decout, D., Strecker, G., Spik, G., Montreuil, J., Specificity of twelve lectins towards oligosaccharides and glycopeptides related to N-glycosylproteins. Eur. J. Biochem. 1981, 117, 41-55.
76. Gabius, H.-J., Gabius, S., Glycosciences: Status and Perspectives, Chapman & Hall, Weinheim 1997.
77. Cummings, R. D., Use of lectins in analysis of glycoconjugates. Methods Enzymol. 1994, 230, 66-86.
78. Bedair, M., El Rassi, Z., Affinity chromatography with monolithic capillary columns. II. Polymethacrylate monoliths with immobilized lectins for the separation of glycoconjugates by nano-liquid affinity chromatography. J. Chromatogr. A. 2005, 1079, 236-245.
79. Jung, K., Cho, W., Regnier, F. E., Glycoproteomics of plasma based on narrow selectivity lectin affinity chromatography. J. Proteome Res. 2009, 8, 643-650.
80. Plavina, T., Wakshull, E., Hancock, W. S., Hincapie, M., Combination of abundant protein depletion and multi-lectin affinity chromatography (M-LAC) for plasma protein biomarker discovery. J. Proteome Res. 2007, 6, 662-671.
81. Kullolli, M., Hancock, W. S., Hincapie, M., Preparation of a high-performance multi-lectin affinity chromatography (HP-M-LAC) adsorbent for the analysis of human plasma glycoproteins. J. Sep. Sci. 2008, 31, 2733-2739.
82. Kullolli, M., Hancock, W. S., Hincapie, M., Automated platform for fractionation of human plasma glycoproteome in clinical proteomics. Anal. Chem. 2010, 82, 115-120.
83. Mortezai, N., Wagener, C., Buck, F., Combining lectin affinity chromatography and immunodepletion-a novel method for the enrichment of disease-specific glycoproteins in human plasma. Methods 2012, 56, 254-259.
84. Tep, S., Hincapie, M., Hancock, W. S., A general approach for the purification and quantitative glycomic analysis of human plasma. Anal. Bioanal. Chem. 2012, 402, 2687-2700.
85. Tao, S. C., Li, Y., Zhou, J., Qian, J. et al., Lectin microarrays identify cell-specific and functionally significant cell surface glycan markers. Glycobiology 2008, 18, 761-769.
86. Wang, Y. C., Nakagawa, M., Garitaonandia, I., Slavin, I. et al., Specific lectin biomarkers for isolation of human pluripotent stem cells identified through array-based glycomic analysis. Cell Res. 2011, 21, 1551-1563.
87. Nasi, A., Picariello, G., Ferranti, P., Proteomic approaches to study structure, functions and toxicity of legume seeds lectins. Perspectives for the assessment of food quality and safety. J. Proteomics 2009, 72, 527-538.
88. Manza, L. L., Stamer, S. L., Ham, A. J., Codreanu, S. G., Liebler, D. C., Sample preparation and digestion for proteomic analyses using spin filters. Proteomics 2005, 5, 1742-1745.
89. Zielinska, D. F., Gnad, F., Wisniewski, J. R., Mann, M., Precision mapping of an in vivo N-glycoproteome reveals rigid topological and sequence constraints. Cell 2010, 141, 897-907.
90. Chen, S., LaRoche, T., Hamelinck, D., Bergsma, D. et al., Multiplexed analysis of glycan variation on native proteins captured by antibody microarrays. Nat. Methods 2007, 4, 437-444.
91. Haab, B. B., Antibody-lectin sandwich arrays for biomarker and glycobiology studies. Expert Rev. Proteomics 2010, 7, 9-11.
92. Chazotte, B., Labeling membrane glycoproteins or glycolipids with fluorescent wheat germ agglutinin. Cold Spring Harb. Protoc. 2011, 2011, 570-572.
93. Kostrominova, T. Y., Application of WGA lectin staining for visualization of the connective tissue in skeletal muscle, bone, and ligament/tendon studies. Microsc. Res. Tech. 2011, 74, 18-22.
94. Thingholm, T. E., Jorgensen, T. J., Jensen, O. N., Larsen, M. R., Highly selective enrichment of phosphorylated peptides using titanium dioxide. Nat. Protoc. 2006, 1, 1929-1935.
95. Larsen, M. R., Jensen, S. S., Jakobsen, L. A., Heegaard, N. H., Exploring the sialiome using titanium dioxide chromatography and mass spectrometry. Mol. Cell Proteomics 2007, 6, 1778-1787.
96. Wohlgemuth, J., Karas, M., Eichhorn, T., Hendriks, R., Andrecht, S., Quantitative site-specific analysis of protein glycosylation by LC-MS using different glycopeptide-enrichment strategies. Anal. Biochem. 2009, 395, 178-188.
97. Alpert, A. J., Hydrophilic-interaction chromatography for the separation of peptides, nucleic acids and other polar compounds. J. Chromatogr. 1990, 499, 177-196.
98. Yeh, C. H., Chen, S. H., Li, D. T., Lin, H. P. et al., Magnetic bead-based hydrophilic interaction liquid chromatography for glycopeptide enrichments. J. Chromatogr. A. 2012, 1224, 70-78.
99. Parker, B. L., Gupta, P., Cordwell, S. J., Larsen, M. R., Palmisano, G., Purification and identification of O-GlcNAc-modified peptides using phosphate-based alkyne CLICK chemistry in combination with titanium dioxide chromatography and mass spectrometry. J. Proteome Res. 2011, 10, 1449-1458.
100. Palmisano, G., Parker, B. L., Engholm-Keller, K., Lendal, S. E. et al., A novel method for the simultaneous enrichment, identification and quantification of phosphopeptides and sialylated glycopeptides applied to a temporal profile of mouse brain development. Mol. Cell Proteomics 2012, 11, 1191-1202.
101. An, H. J., Peavy, T. R., Hedrick, J. L., Lebrilla, C. B., Determination of N-glycosylation sites and site heterogeneity in glycoproteins. Anal. Chem. 2003, 75, 5628-5637.
102. Clowers, B. H., Dodds, E. D., Seipert, R. R., Lebrilla, C. B., Site determination of protein glycosylation based on digestion with immobilized nonspecific proteases and Fourier transform ion cyclotron resonance mass spectrometry. J. Proteome Res. 2007, 6, 4032-4040.
103. Seipert, R. R., Dodds, E. D., Clowers, B. H., Beecroft, S. M. et al., Factors that influence fragmentation behavior of N-linked glycopeptide ions. Anal. Chem. 2008, 80, 3684-3692.
104. Seipert, R. R., Dodds, E. D., Lebrilla, C. B., Exploiting differential dissociation chemistries of O-linked glycopeptide ions for the localization of mucin-type protein glycosylation. J. Proteome Res. 2009, 8, 493-501.
105. Dodds, E. D., Seipert, R. R., Clowers, B. H., German, J. B., Lebrilla, C. B., Analytical performance of immobilized pronase for glycopeptide footprinting and implications for surpassing reductionist glycoproteomics. J. Proteome Res. 2009, 8, 502-512.
106. Nwosu, C. C., Seipert, R. R., Strum, J. S., Hua, S. S. et al., Simultaneous and extensive site-specific N- and O-glycosylation analysis in protein mixtures. J. Proteome Res. 2011, 10, 2612-2624.
107. Segu, Z. M., Hussein, A., Novotny, M. V., Mechref, Y., Assigning N-glycosylation sites of glycoproteins using LC/MSMS in conjunction with endo-M/exoglycosidase mixture. J. Proteome Res. 2010, 9, 3598-3607.
108. Hagglund, P., Matthiesen, R., Elortza, F., Hojrup, P. et al., An enzymatic deglycosylation scheme enabling identification of core fucosylated N-glycans and O-glycosylation site mapping of human plasma proteins. J. Proteome Res. 2007, 6, 3021-3031.
109. Triguero, A., Cabrera, G., Royle, L., Harvey, D. J. et al., Chemical and enzymatic N-glycan release comparison for N-glycan profiling of monoclonal antibodies expressed in plants. Anal. Biochem. 2010, 400, 173-183.
110. Palmisano, G., Melo-Braga, M. N., Engholm-Keller, K., Parker, B. L., Larsen, M. R., Chemical deamidation: a common pitfall in large-scale N-linked glycoproteomic mass spectrometry-based analyses. J. Proteome Res. 2012, 11, 1949-1957.
111. Gu, Y., Wu, S. L., Meyer, J. L., Hancock, W. S. et al., Proteomic analysis of high-grade dysplastic cervical cells obtained from ThinPrep slides using laser capture microdissection and mass spectrometry. J. Proteome Res. 2007, 6, 4256-4268.
112. Enoksson, M., Li, J., Ivancic, M. M., Timmer, J. C. et al., Identification of proteolytic cleavage sites by quantitative proteomics. J. Proteome Res. 2007, 6, 2850-2858.
113. Kitteringham, N. R., Jenkins, R. E., Lane, C. S., Elliott, V. L., Park, B. K., Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2009, 877, 1229-1239.
114. Jakoby, T., van den Berg, B. H., Tholey, A., Quantitative protease cleavage site profiling using tandem-mass-tag labeling and LC-MALDI-TOF/TOF MS/MS analysis. J. Proteome Res. 2012, 11, 1812-1820.
115. Morelle, W., Faid, V., Chirat, F., Michalski, J. C., Analysis of N- and O-linked glycans from glycoproteins using MALDI-TOF mass spectrometry. Methods Mol. Biol. 2009, 534, 5-21.
116. Lastovickova, M., Chmelik, J., Bobalova, J., The combination of simple MALDI matrices for the improvement of intact glycoproteins and glycans analysis. Int. J. Mass Spectrom. 2009, 281, 82-88.
117. Gimenez, E., Benavente, F., Barbosa, J., Sanz-Nebot, V., Ionic liquid matrices for MALDI-TOF-MS analysis of intact glycoproteins. Anal. Bioanal. Chem. 2010, 398, 357-365.
118. Karas, M., Bahr, U., Strupat, K., Hillenkamp, F. et al., Matrix dependence of metastable fragmentation of glycoproteins in MALDI TOF mass-spectrometry. Anal. Chem. 1995, 67, 675-679.
119. Claydon, A. J., Beynon, R. J., Protein turnover methods in single-celled organisms: dynamic SILAC. Methods Mol. Biol. 2011, 759, 179-195.
120. Mann, M., Functional and quantitative proteomics using SILAC. Nat. Rev. Mol. Cell. Biol. 2006, 7, 952-958.
121. Beynon, R. J., Pratt, J. M., Metabolic labeling of proteins for proteomics. Mol. Cell Proteomics 2005, 4, 857-872.
122. Zanivan, S., Krueger, M., Mann, M., In vivo quantitative proteomics: the SILAC mouse. Methods Mol. Biol. 2012, 757, 435-450.
123. Hayter, J. R., Doherty, M. K., Whitehead, C., McCormack, H. et al., The subunit structure and dynamics of the 20S proteasome in chicken skeletal muscle. Mol. Cell Proteomics 2005, 4, 1370-1381.
124. Wang, Z., Pandey, A., Hart, G. W., Dynamic interplay between O-linked N-acetylglucosaminylation and glycogen synthase kinase-3-dependent phosphorylation. Mol. Cell Proteomics 2007, 6, 1365-1379.
125. Schmidt, A., Kellermann, J., Lottspeich, F., A novel strategy for quantitative proteomics using isotope-coded protein labels. Proteomics 2005, 5, 4-15.
126. Ross, P. L., Huang, Y. N., Marchese, J. N., Williamson, B. et al., Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell Proteomics 2004, 3, 1154-1169.
127. Zolg, J. W., Langen, H., How industry is approaching the search for new diagnostic markers and biomarkers. Mol. Cell Proteomics 2004, 3, 345-354.
128. Baker, M., In biomarkers we trust? Nat. Biotechnol. 2005, 23, 297-304.
129. Hung, K. E., Kho, A. T., Sarracino, D., Richard, L. G. et al., Mass spectrometry-based study of the plasma proteome in a mouse intestinal tumor model. J. Proteome Res. 2006, 5, 1866-1878.
130. Pratt, J. M., Simpson, D. M., Doherty, M. K., Rivers, J. et al., Multiplexed absolute quantification for proteomics using concatenated signature peptides encoded by QconCAT genes. Nat. Protoc. 2006, 1, 1029-1043.
131. Huber, L. A., Is proteomics heading in the wrong direction? Nat. Rev. Mol. Cell Biol. 2003, 4, 74-80.
132. Kuhn, E., Wu, J., Karl, J., Liao, H. et al., Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards. Proteomics 2004, 4, 1175-1186.
133. Stahl-Zeng, J., Lange, V., Ossola, R., Eckhardt, K. et al., High sensitivity detection of plasma proteins by multiple reaction monitoring of N-glycosites. Mol. Cell Proteomics 2007, 6, 1809-1817.
134. Jaffe, J. D., Keshishian, H., Chang, B., Addona, T. A. et al., Accurate inclusion mass screening: a bridge from unbiased discovery to targeted assay development for biomarker verification. Mol. Cell Proteomics 2008, 7, 1952-1962.
135. Gillet, L. C., Navarro, P., Tate, S., Rost, H. et al., Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol. Cell Proteomics 2012, 11, O111 016717.
136. Gallien, S., Peterman, S., Kiyonami, R., Souady, J. et al., Highly multiplexed targeted proteomics using precise control of peptide retention time. Proteomics 2012, 12, 1122-1133.
137. Baycin-Hizal, D., Tian, Y., Akan, I., Jacobson, E. et al., GlycoFish: a database of zebrafish N-linked glycoproteins identified using SPEG method coupled with LC/MS. Anal. Chem. 2011, 83, 5296-5303.
138. Baycin-Hizal, D., Tian, Y., Akan, I., Jacobson, E. et al., GlycoFly: a database of Drosophila N-linked glycoproteins identified using SPEG-MS techniques. J. Proteome Res. 2011, 10, 2777-2784.
139. Lai, Z. W., Steer, D. L., Smith, A. I., Membrane proteomics: the development of diagnostics based on protein shedding. Curr. Opin. Mol. Ther. 2009, 11, 623-631.
140. Domon, B., Aebersold, R., Options and considerations when selecting a quantitative proteomics strategy. Nat. Biotechnol. 2010, 28, 710-721.
141. Cho, W., Jung, K., Regnier, F. E., Use of glycan targeting antibodies to identify cancer-associated glycoproteins in plasma of breast cancer patients. Anal. Chem. 2008, 80, 5286-5292.
142. Varki, A., Etzler, M. E., Cummings, R. D., Esko, J. D., in: Varki, A. et al., (Eds.), Essentials of Glycobiology, Cold Spring Harbor, NY 2009.